Related Experiment Video
Updated: Aug 9, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Therapeutic potential of RNAi in metabolic diseases
1Department Metabolic Diseases, Hoffmann-La Roche, Nutley, NJ 07110, USA. cristina.rondinone@roche.com
Abstract:
Over the past years RNA interference (RNAi) has exploded as a new approach to manipulate gene expression in mammalian systems. More recently, RNAi has acquired interest as a potential therapeutic strategy. This review focuses on the potential therapeutic use of RNAi for metabolic diseases, the current understanding of RNAi biology, and how RNAi has been utilized to study the role of different genes in the pathogenesis of diabetes and obesity. Also reviewed are the in vivo proof-of-principle experiments that provide the preclinical justification for the development of RNAi-based therapeutics for diabetes and the key challenges that currently limit its application in the clinical setting.
Insights
RNA interference (RNAi) offers a promising therapeutic strategy for metabolic diseases like diabetes and obesity. This review explores RNAi biology, its application in disease research, and challenges for clinical use.
Area of Science:
- Biochemistry and Molecular Biology
- Genetics and Genomics
- Metabolic Disease Research
Background:
- RNA interference (RNAi) is a powerful tool for gene expression manipulation in mammals.
- RNAi is emerging as a significant potential therapeutic strategy.
- Metabolic diseases, including diabetes and obesity, are major health concerns.
Purpose of the Study:
- To review the therapeutic potential of RNAi for metabolic diseases.
- To discuss the current understanding of RNAi biology.
- To examine the use of RNAi in studying diabetes and obesity pathogenesis.
Main Methods:
- Literature review of RNAi applications in metabolic disease research.
- Analysis of in vivo proof-of-principle experiments.
- Identification of challenges for clinical translation.
Main Results:
- RNAi has been effectively used to investigate gene roles in diabetes and obesity.
- Preclinical studies demonstrate the potential of RNAi therapeutics for diabetes.
- Significant challenges remain for the clinical application of RNAi.
Conclusions:
- RNAi holds considerable promise as a therapeutic approach for metabolic disorders.
- Further research and development are needed to overcome clinical limitations.
- RNAi-based therapies could revolutionize metabolic disease treatment.
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Types of RNA
RNA Performs Diverse...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...